Tata Memorial Centre

The Tata Memorial Center (TMC) is an autonomous grant-in-aid institution administered under the Department of Atomic Energy, Government of India. The TMC umbrella includes at least 10 cancer institutes across India, the largest and the central hub of which is the Tata Memorial Hospital (TMH) in Parel, Mumbai, is India's oldest and largest cancer institute.

It has spearheaded the Evidence-based Medicine (EBM) movement in oncology in India, and prioritizes Multidisciplinary Team (MDT) management through disease-specific groups, to ensure quality patient care.

There are many firsts to the TMC name. These include India's first linear accelerator for radiation therapy in 1978, bone marrow transplant in 1983, tissue bank in 1988, PET/CT in 2004, and the first proton therapy unit in a government setup (and second overall) in 2023. It has spearheaded the CAR-T cell trial which has led to the approval indigenous CAR-T cell therapy in India. Importantly, with a mission centered on comprehensive compassionate cancer care for all, approximately 60% of patients receive free or highly subsidized treatments. It is an autonomous institution under the administrative control of Department of Atomic Energy, Government of India. Its current Director is Dr. Sudeep Gupta.